BIO-FD&C Co.,Ltd. (KOSDAQ: A251120)
Health Care · Biotechnology · KR
₩10,240.00
+1.19% today · -39.4% 1Y
BIO-FD&C Co.,Ltd. (KOSDAQ: A251120) operates in the Biotechnology industry within the Health Care sector. The company is valued at $66.79M.
Over the last twelve months the share price has lost 39.4%, trading between 6.33K and 17.73K.
Tweenvest scores BIO-FD&C Co.,Ltd. across four factors: quality 93/100, value 93/100. Its strongest factor is quality.
A251120 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $66.79M
- Revenue (TTM)
- $12.61M
- P/E
- 13.65
- EPS
- 750.17
- Dividend yield
- —
- Beta (5Y)
- 0.36
- 52-week high
- ₩17,730.00
- 52-week low
- ₩6,330.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.70M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Heron Therapeutics, Inc.NasdaqCM: HRTX | $68.54M | $0.36 | -11.11% |
| Libo Pharma Corp.TPEX: 7888 | $68.06M | NT$29.35 | -3.77% |
| Artgen Biotech PJSCMISX: ISKJ | $68.01M | RUB— | — |
| MAIA Biotechnology, Inc.NYSEAM: MAIA | $66.91M | $1.10 | -9.84% |
| Curasight A/SNGM: CURAS | $66.59M | Dkr— | — |
| Bonus BioGroup Ltd.TASE: BONS | $66.29M | ₪0.18 | +2.92% |
| Lytix Biopharma ASAOB: LYTIX | $65.15M | Nkr8.00 | -2.44% |
| StemRIMTSE: 4599 | $65.11M | ¥164.00 | -6.29% |
Figures last refreshed Oct 18, 2026.